Boemo ba Khoebo
Beijing Succeeder Technology Inc. (eo ho tloha ka nako eo e tla bitsoa SUCCEEDER), e fumaneha Life Science Park Beijing Chaena, e thehiloeng ka 2003, SUCCEEDER e ikhethang ka lihlahisoa tsa tlhahlobo ea thrombosis le hemostasis bakeng sa 'maraka oa lefats'e.
Jwalo ka e nngwe ya matshwao a etellang pele mmarakeng wa Tlhahlobo ya Thrombosis le Hemostasis wa Chaena, SUCCEEDER e na le dihlopha tsa R&D, Tlhahiso, Papatso, Thekiso le Tshebeletso, e Fanang ka di-analyzer tsa coagulation le di-reagent, di-analyzer tsa rheology ya madi, di-analyzer tsa ESR le HCT, di-analyzer tsa ho kopanya diplatelet, tse nang le ISO 13485, Setifikeiti sa CE, le FDA tse thathamisitsweng.
R&D
Jwalo ka e nngwe ya matshwao a etellang pele mmarakeng wa Tlhahlobo ya Thrombosis le Hemostasis wa Chaena, SUCCEEDER e na le dihlopha tsa R&D, Tlhahiso, Papatso, Thekiso le Tshebeletso, e Fanang ka di-analyzer tsa coagulation le di-reagent, di-analyzer tsa rheology ya madi, di-analyzer tsa ESR le HCT, di-analyzer tsa ho kopanya diplatelet, tse nang le ISO 13485, Setifikeiti sa CE, le FDA tse thathamisitsweng.
Ho tloha ha e theoa ka 2003, Succeeder e 'nile ea ikemisetsa ho etsa lipatlisiso le nts'etsopele, tlhahiso le thekiso ea lisebelisoa tsa liteko, li-reagent le lintho tse sebelisoang lefapheng la thrombosis le hemostasis in vitro diagnostics, e fa litsi tsa bongaka lisebelisoa tsa tlhahlobo tse iketsang bakeng sa ho hoama ha mali, rheology ea mali, hematocrit, ho bokellana ha liplatelete, li-reagent tse tšehetsang le lintho tse sebelisoang. Succeeder ow ke moetsi ea ka sehloohong oa Chaena lefapheng la tlhahlobo ea thrombosis le hemostasis in vitro.
Theknoloji ea mantlha ea Succeeder e akaretsang lisebelisoa, li-reagent le lintho tse sebelisoang e thehiloe, ka bokhoni bo ikhethang ba R&D le boqapi ba theknoloji. Hona joale, e na le mekhahlelo e mehlano ea mantlha ea theknoloji: sethala sa theknoloji ea tekanyo ea rheology ea mali, sethala sa theknoloji ea tlhahlobo ea ho kopana ha mali, sethala sa theknoloji ea lintho tse tala tsa baeloji, theknoloji ea mantlha ea li-reagent tsa tlhahlobo ea ho kopana ha mali, le mekhoa ea ho latela.
Ketsahalo ea Bohlokoa
Boleng
Ho ntlafatsa theknoloji ea ho lekanya le boemo ba othomathiki ba liteko tsa ho kopana ha mali tse seng li ntse li le teng le liteko tsa rheology ea mali;
(2) Mohala oa ho kopanya mali oa R&D, teko ea ho kopanya mali ka boiketsetso e potlakileng, teko ea rheology ea mali ka boiketsetso e potlakileng, teko ea ho hlahloba tšebetso ea platelet ka boiketsetso le chate ea thromboelasticity le letoto le leng la lihlahisoa;
(3) Hlokomela tlhahiso e ikemetseng ea thepa ea bohlokoa ea bohlokoa e holimo, e itšetlehileng ka sethala sa theknoloji ea lintho tse tala tsa baeloji, Ntlafatsa boleng le ts'ebetso ea lihlahisoa tsa reagent;
(4) Hlahisa vWF, LA, PC, PS, Anti-Xa, tekanyo ea nako ea thrombin e diluted (dTT), blood coagulation factor VIII le blood coagulation factor IX le li-reagent tse ling tsa tlhahlobo ea in vitro le ho tšehetsa taolo ea boleng Lihlahisoa le lihlahisoa tse tloaelehileng li fihlela litlhoko tsa bongaka bakeng sa tlhahlobo le tlhokomelo ea thrombus, antiphospholipid syndrome, hemophilia le mafu a mang, le ho boloka melemo ea profeshenale ea Succeeder lefapheng la tlhahlobo ea thrombosis le hemostasis in vitro.
Setifikeiti
Karete ea khoebo
WeChat ea Sechaena